ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

NCT06328738 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

275

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2-positive Breast Cancer
HER2-positive Gastric Cancer
HER2 Positive Solid Tumors
HER2 Amplification
Colorectal Cancer

Interventions

DRUG: ELVN-002
DRUG: Trastuzumab
DRUG: 5-Fluorouracil
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Eribulin
DRUG: paclitaxel
DRUG: Leucovorin

Sponsor

Enliven Therapeutics